ID   IGF2_HUMAN              Reviewed;         180 AA.
AC   P01344; B3KX48; B7WP08; P78449; Q14299; Q1WM26; Q9UC68; Q9UC69;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   21-MAR-2012, entry version 163.
DE   RecName: Full=Insulin-like growth factor II;
DE            Short=IGF-II;
DE   AltName: Full=Somatomedin-A;
DE   Contains:
DE     RecName: Full=Insulin-like growth factor II;
DE   Contains:
DE     RecName: Full=Insulin-like growth factor II Ala-25 Del;
DE   Contains:
DE     RecName: Full=Preptin;
DE   Flags: Precursor;
GN   Name=IGF2; ORFNames=PP1446;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   MEDLINE=84295593; PubMed=6382022; DOI=10.1038/310777a0;
RA   Dull T.J., Gray A., Hayflick J.S., Ullrich A.;
RT   "Insulin-like growth factor II precursor gene organization in relation
RT   to insulin gene family.";
RL   Nature 310:777-781(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=84295592; PubMed=6382021; DOI=10.1038/310775a0;
RA   Bell G.I., Merryweather J.P., Sanchez-Pescador R., Stempien M.M.,
RA   Priestley L., Scott J., Rall L.B.;
RT   "Sequence of a cDNA clone encoding human preproinsulin-like growth
RT   factor II.";
RL   Nature 310:775-777(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=88158110; PubMed=2450353; DOI=10.1073/pnas.85.6.1947;
RA   Shen S.-J., Daimon M., Wang C.-Y., Jansen M., Ilan J.;
RT   "Isolation of an insulin-like growth factor II cDNA with a unique 5'
RT   untranslated region from human placenta.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:1947-1951(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   MEDLINE=86108862; PubMed=3002851; DOI=10.1016/0014-5793(86)80156-9;
RA   de Pagter-Holthuizen P., van Schaik F.M.A., Verduijn G.M.,
RA   van Ommen G.J.B., Bouma B.N., Jansen M., Sussenbach J.S.;
RT   "Organization of the human genes for insulin-like growth factors I and
RT   II.";
RL   FEBS Lett. 195:179-184(1986).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=87317645; PubMed=3476948; DOI=10.1073/pnas.84.18.6330;
RA   Irminger J.C., Rosen K.M., Humbel R.E., Villa-Komaroff L.;
RT   "Tissue-specific expression of insulin-like growth factor II mRNAs
RT   with distinct 5' untranslated regions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:6330-6334(1987).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=88065102; PubMed=3683205;
RA   Rall L.B., Scott J., Bell G.I.;
RT   "Human insulin-like growth factor I and II messenger RNA: isolation of
RT   complementary DNA and analysis of expression.";
RL   Methods Enzymol. 146:239-248(1987).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   MEDLINE=85102019; PubMed=3881277; DOI=10.1016/0014-5793(85)80527-5;
RA   Jansen M., van Schaik F.M.A., van Tol H., van den Brande J.L.,
RA   Sussenbach J.S.;
RT   "Nucleotide sequences of cDNAs encoding precursors of human insulin-
RT   like growth factor II (IGF-II) and an IGF-II variant.";
RL   FEBS Lett. 179:243-246(1985).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=95247546; PubMed=7730145;
RA   Hagiwara K., Kobayashi T., Tobita M., Kikyo N., Yazaki Y., Okabe T.;
RT   "Isolation of a cDNA for a growth factor of vascular endothelial cells
RT   from human lung cancer cells: its identity with insulin-like growth
RT   factor II.";
RL   Jpn. J. Cancer Res. 86:202-207(1995).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=16531418; DOI=10.1093/hmg/ddl041;
RA   Monk D., Sanches R., Arnaud P., Apostolidou S., Hills F.A.,
RA   Abu-Amero S., Murrell A., Friess H., Reik W., Stanier P.,
RA   Constancia M., Moore G.E.;
RT   "Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-
RT   IGF2 isoforms show differences between mouse and human.";
RL   Hum. Mol. Genet. 15:1259-1269(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 103-180.
RX   MEDLINE=89000779; PubMed=3167054; DOI=10.1016/0167-4781(88)90124-8;
RA   de Pagter-Holthuizen P., van der Kammen R.A., Jansen M.,
RA   van Schaik F.M.A., Sussenbach J.S.;
RT   "Differential expression of the human insulin-like growth factor II
RT   gene. Characterization of the IGF-II mRNAs and an mRNA encoding a
RT   putative IGF-II-associated protein.";
RL   Biochim. Biophys. Acta 950:282-295(1988).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-161 (ISOFORM 2).
RX   MEDLINE=88005137; PubMed=3653397; DOI=10.1016/0014-5793(87)80216-8;
RA   le Bouc Y., Noguiez P., Sondermeijer P., Dreyer D., Girard F.,
RA   Binoux M.;
RT   "A new 5'-non-coding region for human placental insulin-like growth
RT   factor II mRNA expression.";
RL   FEBS Lett. 222:181-185(1987).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-52.
RC   TISSUE=Liver;
RX   MEDLINE=88003966; PubMed=3652904;
RA   Gray A., Tam A.W., Dull T.J., Hayflick J.S., Pintar J., Cavenee W.K.,
RA   Koufos A., Ullrich A.;
RT   "Tissue-specific and developmentally regulated transcription of the
RT   insulin-like growth factor 2 gene.";
RL   DNA 6:283-295(1987).
RN   [20]
RP   PROTEIN SEQUENCE OF 25-91.
RX   MEDLINE=78191259; PubMed=658418; DOI=10.1016/0014-5793(78)80237-3;
RA   Rinderknecht E., Humbel R.E.;
RT   "Primary structure of human insulin-like growth factor II.";
RL   FEBS Lett. 89:283-286(1978).
RN   [21]
RP   PARTIAL PROTEIN SEQUENCE, AND DISULFIDE BONDS.
RX   MEDLINE=89255428; PubMed=2722836;
RA   Smith M.C., Cook J.A., Furman T.C., Occolowitz J.L.;
RT   "Structure and activity dependence of recombinant human insulin-like
RT   growth factor II on disulfide bond pairing.";
RL   J. Biol. Chem. 264:9314-9321(1989).
RN   [22]
RP   PROTEIN SEQUENCE OF 25-68.
RX   MEDLINE=95360205; PubMed=7633596; DOI=10.1016/0378-4347(94)00576-Q;
RA   De Ceuninck F., Willeput J., Corvol M.;
RT   "Purification and characterization of insulin-like growth factor II
RT   (IGF II) and an IGF II variant from human placenta.";
RL   J. Chromatogr. B 666:203-214(1995).
RN   [23]
RP   POLYMORPHISM, AND ASSOCIATION WITH WITH BODY MASS INDEX.
RX   PubMed=11448941; DOI=10.1093/hmg/10.14.1491;
RA   Gaunt T.R., Cooper J.A., Miller G.J., Day I.N.M., O'Dell S.D.;
RT   "Positive associations between single nucleotide polymorphisms in the
RT   IGF2 gene region and body mass index in adult males.";
RL   Hum. Mol. Genet. 10:1491-1501(2001).
RN   [24]
RP   MASS SPECTROMETRY, AND PROTEOLYTIC PROCESSING.
RX   MEDLINE=22474139; PubMed=12586351; DOI=10.1016/S0014-5793(03)00042-5;
RA   Nedelkov D., Nelson R.W., Kiernan U.A., Niederkofler E.E., Tubbs K.A.;
RT   "Detection of bound and free IGF-1 and IGF-2 in human plasma via
RT   biomolecular interaction analysis mass spectrometry.";
RL   FEBS Lett. 536:130-134(2003).
RN   [25]
RP   MASS SPECTROMETRY, AND PROTEOLYTIC PROCESSING.
RX   PubMed=15359740; DOI=10.1021/pr0499388;
RA   Nelson R.W., Nedelkov D., Tubbs K.A., Kiernan U.A.;
RT   "Quantitative mass spectrometric immunoassay of insulin like growth
RT   factor 1.";
RL   J. Proteome Res. 3:851-855(2004).
RN   [26]
RP   GLYCOSYLATION AT THR-99.
RX   MEDLINE=92235026; PubMed=1569071;
RA   Hudgins W.R., Hampton B., Burgess W.H., Perdue J.F.;
RT   "The identification of O-glycosylated precursors of insulin-like
RT   growth factor II.";
RL   J. Biol. Chem. 267:8153-8160(1992).
RN   [27]
RP   OSTEOGENIC FUNCTION OF PREPTIN.
RX   PubMed=16912056; DOI=10.1152/ajpendo.00642.2005;
RA   Cornish J., Callon K.E., Bava U., Watson M., Xu X., Lin J.M.,
RA   Chan V.A., Grey A.B., Naot D., Buchanan C.M., Cooper G.J., Reid I.R.;
RT   "Preptin, another peptide product of the pancreatic beta-cell, is
RT   osteogenic in vitro and in vivo.";
RL   Am. J. Physiol. 292:E117-E122(2007).
RN   [28]
RP   INVOLVEMENT IN SRS.
RX   PubMed=19066168; DOI=10.1136/jmg.2008.061820;
RA   Bartholdi D., Krajewska-Walasek M., Ounap K., Gaspar H.,
RA   Chrzanowska K.H., Ilyana H., Kayserili H., Lurie I.W., Schinzel A.,
RA   Baumer A.;
RT   "Epigenetic mutations of the imprinted IGF2-H19 domain in Silver-
RT   Russell syndrome (SRS): results from a large cohort of patients with
RT   SRS and SRS-like phenotypes.";
RL   J. Med. Genet. 46:192-197(2009).
RN   [29]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT THR-163, STRUCTURE OF
RP   CARBOHYDRATES, AND MASS SPECTROMETRY.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=19838169; DOI=10.1038/nmeth.1392;
RA   Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,
RA   Brinkmalm G., Larson G.;
RT   "Enrichment of glycopeptides for glycan structure and attachment site
RT   identification.";
RL   Nat. Methods 6:809-811(2009).
RN   [30]
RP   3D-STRUCTURE MODELING.
RX   MEDLINE=83210259; PubMed=6189745;
RA   Blundell T.L., Bedarkar S., Humbel R.E.;
RT   "Tertiary structures, receptor binding, and antigenicity of
RT   insulinlike growth factors.";
RL   Fed. Proc. 42:2592-2597(1983).
RN   [31]
RP   STRUCTURE BY NMR.
RX   MEDLINE=95080243; PubMed=7527339;
RA   Terasawa H., Kohda D., Hatanaka H., Nagata K., Higashihashi N.,
RA   Fujiwara H., Sakano K., Inagaki F.;
RT   "Solution structure of human insulin-like growth factor II;
RT   recognition sites for receptors and binding proteins.";
RL   EMBO J. 13:5590-5597(1994).
CC   -!- FUNCTION: The insulin-like growth factors possess growth-promoting
CC       activity. In vitro, they are potent mitogens for cultured cells.
CC       IGF-II is influenced by placental lactogen and may play a role in
CC       fetal development.
CC   -!- FUNCTION: Preptin undergoes glucose-mediated co-secretion with
CC       insulin, and acts as physiological amplifier of glucose-mediated
CC       insulin secretion. Exhibits osteogenic properties by increasing
CC       osteoblast mitogenic activity through phosphoactivation of MAPK1
CC       and MAPK3.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P01344-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P01344-2; Sequence=VSP_002708;
CC   -!- PTM: O-glycosylated with a core 1 or possibly core 8 glycan.
CC   -!- MASS SPECTROMETRY: Mass=7469.4; Method=MALDI; Range=25-91;
CC       Source=PubMed:12586351, PubMed:15359740;
CC   -!- MASS SPECTROMETRY: Mass=7398.3; Method=MALDI; Range=26-91;
CC       Source=PubMed:12586351, PubMed:15359740;
CC   -!- POLYMORPHISM: Genetic variations in IGF2 are associated with body
CC       mass index (BMI). The BMI is a statistical measurement which
CC       compares a person's weight and height.
CC   -!- DISEASE: Epigenetic changes of DNA hypomethylation in IGF2 are a
CC       cause of Silver-Russell syndrome (SRS) [MIM:180860]. A clinically
CC       heterogeneous condition characterized by severe intrauterine
CC       growth retardation, poor postnatal growth, craniofacial features
CC       such as a triangular shaped face and a broad forehead, body
CC       asymmetry, and a variety of minor malformations. The phenotypic
CC       expression changes during childhood and adolescence, with the
CC       facial features and asymmetry usually becoming more subtle with
CC       age.
CC   -!- SIMILARITY: Belongs to the insulin family.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/IGF2";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Insulin-like growth factor 2
CC       entry;
CC       URL="http://en.wikipedia.org/wiki/Insulin-like_growth_factor_2";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/igf2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X03562; CAA27249.1; -; Genomic_DNA.
DR   EMBL; X00910; CAA25426.1; -; mRNA.
DR   EMBL; J03242; AAA52545.1; -; mRNA.
DR   EMBL; X03425; CAA27155.1; -; Genomic_DNA.
DR   EMBL; X03426; CAA27156.1; -; Genomic_DNA.
DR   EMBL; X03427; CAA27157.1; -; Genomic_DNA.
DR   EMBL; M17426; AAA60088.1; -; mRNA.
DR   EMBL; M29645; AAA52544.1; -; mRNA.
DR   EMBL; M17863; AAA52443.1; ALT_SEQ; mRNA.
DR   EMBL; S77035; AAB34155.1; -; mRNA.
DR   EMBL; DQ104203; ABD93451.1; -; mRNA.
DR   EMBL; AF217977; AAG17220.1; -; mRNA.
DR   EMBL; BT007013; AAP35659.1; -; mRNA.
DR   EMBL; AF517226; AAM51825.1; -; Genomic_DNA.
DR   EMBL; AC132217; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK126688; BAG54360.1; -; mRNA.
DR   EMBL; CH471158; EAX02485.1; -; Genomic_DNA.
DR   EMBL; BC000531; AAH00531.1; -; mRNA.
DR   EMBL; X07868; CAA30717.1; -; Genomic_DNA.
DR   EMBL; X06159; CAA29516.1; -; mRNA.
DR   EMBL; X06160; CAA29517.1; -; Transcribed_RNA.
DR   EMBL; X06161; CAA29518.1; -; mRNA.
DR   EMBL; M22373; AAA52536.1; -; Genomic_DNA.
DR   IPI; IPI00001611; -.
DR   IPI; IPI00940065; -.
DR   PIR; B23614; IGHU2.
DR   PIR; I67610; I67610.
DR   PIR; S02423; S02423.
DR   RefSeq; NP_000603.1; NM_000612.4.
DR   RefSeq; NP_001007140.2; NM_001007139.4.
DR   UniGene; Hs.272259; -.
DR   PDB; 1GF2; Model; -; A=25-91.
DR   PDB; 1IGL; NMR; -; A=25-91.
DR   PDB; 2V5P; X-ray; 4.10 A; C/D=25-91.
DR   PDB; 3E4Z; X-ray; 2.28 A; C/D=25-91.
DR   PDB; 3KR3; X-ray; 2.20 A; D=25-91.
DR   PDBsum; 1GF2; -.
DR   PDBsum; 1IGL; -.
DR   PDBsum; 2V5P; -.
DR   PDBsum; 3E4Z; -.
DR   PDBsum; 3KR3; -.
DR   ProteinModelPortal; P01344; -.
DR   SMR; P01344; 29-88.
DR   DIP; DIP-29508N; -.
DR   DIP; DIP-6026N; -.
DR   MINT; MINT-6380943; -.
DR   STRING; P01344; -.
DR   PhosphoSite; P01344; -.
DR   DMDM; 124255; -.
DR   PRIDE; P01344; -.
DR   DNASU; 3481; -.
DR   Ensembl; ENST00000300632; ENSP00000300632; ENSG00000167244.
DR   Ensembl; ENST00000337883; ENSP00000338297; ENSG00000167244.
DR   Ensembl; ENST00000381389; ENSP00000370796; ENSG00000167244.
DR   Ensembl; ENST00000381395; ENSP00000370802; ENSG00000167244.
DR   Ensembl; ENST00000416167; ENSP00000414497; ENSG00000167244.
DR   Ensembl; ENST00000418738; ENSP00000402047; ENSG00000167244.
DR   GeneID; 3481; -.
DR   KEGG; hsa:3481; -.
DR   UCSC; uc001lvg.1; human.
DR   CTD; 3481; -.
DR   GeneCards; GC11M002113; -.
DR   H-InvDB; HIX0128667; -.
DR   HGNC; HGNC:5466; IGF2.
DR   HPA; CAB024999; -.
DR   HPA; HPA007993; -.
DR   MIM; 147470; gene+phenotype.
DR   MIM; 180860; phenotype.
DR   neXtProt; NX_P01344; -.
DR   Orphanet; 231117; Beckwith-Wiedemann syndrome due to imprinting defect of 11p15.
DR   Orphanet; 2128; Hemihypertrophy.
DR   Orphanet; 231144; Silver-Russell syndrome due to 11p15 microduplication.
DR   Orphanet; 231140; Silver-Russell syndrome due to imprinting defect of 11p15.
DR   eggNOG; NOG44017; -.
DR   GeneTree; ENSGT00530000063856; -.
DR   HOGENOM; HBG505321; -.
DR   HOVERGEN; HBG006137; -.
DR   KO; K13769; -.
DR   OrthoDB; EOG4HMJBH; -.
DR   Reactome; REACT_116125; Disease.
DR   NextBio; 13686; -.
DR   PMAP-CutDB; P01344; -.
DR   ArrayExpress; P01344; -.
DR   Bgee; P01344; -.
DR   CleanEx; HS_IGF2; -.
DR   Genevestigator; P01344; -.
DR   GermOnline; ENSG00000167244; Homo sapiens.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   GO; GO:0008083; F:growth factor activity; IDA:BHF-UCL.
DR   GO; GO:0005179; F:hormone activity; IEA:UniProtKB-KW.
DR   GO; GO:0005158; F:insulin receptor binding; IPI:BHF-UCL.
DR   GO; GO:0005159; F:insulin-like growth factor receptor binding; TAS:ProtInc.
DR   GO; GO:0043539; F:protein serine/threonine kinase activator activity; ISS:BHF-UCL.
DR   GO; GO:0030546; F:receptor activator activity; ISS:BHF-UCL.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0038028; P:insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade; ISS:BHF-UCL.
DR   GO; GO:0001503; P:ossification; IEA:UniProtKB-KW.
DR   GO; GO:0042104; P:positive regulation of activated T cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0051781; P:positive regulation of cell division; IEA:UniProtKB-KW.
DR   GO; GO:2000467; P:positive regulation of glycogen (starch) synthase activity; ISS:BHF-UCL.
DR   GO; GO:0045725; P:positive regulation of glycogen biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:BHF-UCL.
DR   GO; GO:0045840; P:positive regulation of mitosis; IDA:BHF-UCL.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISS:BHF-UCL.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling cascade; IDA:BHF-UCL.
DR   GO; GO:0006349; P:regulation of gene expression by genetic imprinting; TAS:ProtInc.
DR   GO; GO:0006355; P:regulation of transcription, DNA-dependent; NAS:BHF-UCL.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   InterPro; IPR022334; IGF2.
DR   InterPro; IPR013576; IGF2_C.
DR   InterPro; IPR016179; Insulin-like.
DR   InterPro; IPR022350; Insulin-like_growth_factor.
DR   InterPro; IPR022353; Insulin_CS.
DR   InterPro; IPR022352; Insulin_family.
DR   Gene3D; G3DSA:1.10.100.10; Ins/IGF/relaxin; 1.
DR   Pfam; PF08365; IGF2_C; 1.
DR   Pfam; PF00049; Insulin; 2.
DR   PRINTS; PR02002; INSLNLIKEGF.
DR   PRINTS; PR02006; INSLNLIKEGF2.
DR   PRINTS; PR00276; INSULINFAMLY.
DR   ProDom; PD005188; IGF2_C; 1.
DR   SMART; SM00078; IlGF; 1.
DR   SUPFAM; SSF56994; Insulin-like; 1.
DR   PROSITE; PS00262; INSULIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Carbohydrate metabolism;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Dwarfism;
KW   Glucose metabolism; Glycoprotein; Growth factor; Hormone; Mitogen;
KW   Osteogenesis; Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     24
FT   CHAIN        25     91       Insulin-like growth factor II.
FT                                /FTId=PRO_0000015717.
FT   CHAIN        26     91       Insulin-like growth factor II Ala-25 Del.
FT                                /FTId=PRO_0000015718.
FT   PROPEP       92    180       E peptide.
FT                                /FTId=PRO_0000015719.
FT   PEPTIDE      93    126       Preptin.
FT                                /FTId=PRO_0000370376.
FT   REGION       25     52       B.
FT   REGION       53     64       C.
FT   REGION       65     85       A.
FT   REGION       86     91       D.
FT   CARBOHYD     99     99       O-linked (GalNAc...).
FT   CARBOHYD    163    163       O-linked (GalNAc...).
FT   DISULFID     33     71
FT   DISULFID     45     84
FT   DISULFID     70     75
FT   VAR_SEQ      53     53       S -> RLPG (in isoform 2).
FT                                /FTId=VSP_002708.
FT   VARIANT     120    120       K -> N (in dbSNP:rs14367).
FT                                /FTId=VAR_011959.
FT   VARIANT     173    173       P -> Q (in dbSNP:rs1050342).
FT                                /FTId=VAR_011960.
FT   VARIANT     180    180       K -> N (in dbSNP:rs12993).
FT                                /FTId=VAR_011961.
FT   CONFLICT      3      3       I -> M (in Ref. 6; AAA52544).
FT   CONFLICT    107    110       RYPV -> EIPL (in Ref. 1; CAA27249).
FT   CONFLICT    147    147       E -> ELE (in Ref. 5).
FT   HELIX        35     44
FT   HELIX        66     70
FT   HELIX        78     81
SQ   SEQUENCE   180 AA;  20140 MW;  C1B0EB1E016BA37A CRC64;
     MGIPMGKSML VLLTFLAFAS CCIAAYRPSE TLCGGELVDT LQFVCGDRGF YFSRPASRVS
     RRSRGIVEEC CFRSCDLALL ETYCATPAKS ERDVSTPPTV LPDNFPRYPV GKFFQYDTWK
     QSTQRLRRGL PALLRARRGH VLAKELEAFR EAKRHRPLIA LPTQDPAHGG APPEMASNRK
//
